IFIDANCITINIB
UNII R105E71J13

Substance Identification & Data

This profile provides standardized clinical and technical data for Ifidancitinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R105E71J13.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1236667-40-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

R105E71J13

CAS Registry Number

1236667-40-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

IFIDANCITINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C20H18FN5O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

OYFMQDVLFYKOPZ-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C174905

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

46851625

Unique identification number in the NCBI database of chemical substances.

INN ID

11232

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[nH]1c(=O)oc2ccc(Nc3c(C)cnc(Nc4cc(C)c(F)c(OC)c4)n3)cc21

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ifidancitinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.